American Journal of Health-System Pharmacy : AJHP This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Validating identities: The pharmacist's role in providing affirming care and services to sexual and gender minority patients
Am J Health Syst Pharm. 2023 Dec 29:zxad321. doi: 10.1093/ajhp/zxad321. Online ahead of print.ABSTRACTIn an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.PMID:38156465 | DOI:10.1093/ajhp/zxad321 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 29, 2023 Category: Drugs & Pharmacology Authors: E Paul O'Donnell Sally A Arif Source Type: research

Implementation of pharmacist-led services for sexual and gender minorities: A multisite descriptive report
CONCLUSION: The services provided by clinical pharmacists varied across sites and included management of gender-affirming hormone therapy, HIV antiretroviral medication adherence programming, primary care and chronic disease state management, and involvement in care related to mental health, psychiatry, and substance use as well as sexual health. Various legislative and regulatory barriers and differences in scope of practice for pharmacists were also identified. This paper advocates for the expansion of pharmacy-led services and the adoption of a culturally humble approach to patient care.PMID:38156533 | DOI:10.1093/ajhp/...
Source: American Journal of Health-System Pharmacy : AJHP - December 29, 2023 Category: Drugs & Pharmacology Authors: Tam Phan Kevin N Astle Alex R Mills Christopher G Medlin David Herman Source Type: research

Mirikizumab-mrkz
Am J Health Syst Pharm. 2023 Dec 28:zxad301. doi: 10.1093/ajhp/zxad301. Online ahead of print.NO ABSTRACTPMID:38153104 | DOI:10.1093/ajhp/zxad301 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 28, 2023 Category: Drugs & Pharmacology Source Type: research

Vamorolone
Am J Health Syst Pharm. 2023 Dec 28:zxad303. doi: 10.1093/ajhp/zxad303. Online ahead of print.NO ABSTRACTPMID:38153112 | DOI:10.1093/ajhp/zxad303 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 28, 2023 Category: Drugs & Pharmacology Source Type: research

Bimekizumab-bkzx
Am J Health Syst Pharm. 2023 Dec 28:zxad304. doi: 10.1093/ajhp/zxad304. Online ahead of print.NO ABSTRACTPMID:38153141 | DOI:10.1093/ajhp/zxad304 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 28, 2023 Category: Drugs & Pharmacology Source Type: research

Toripalimab-tpzi
Am J Health Syst Pharm. 2023 Dec 28:zxad302. doi: 10.1093/ajhp/zxad302. Online ahead of print.NO ABSTRACTPMID:38153166 | DOI:10.1093/ajhp/zxad302 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 28, 2023 Category: Drugs & Pharmacology Source Type: research

Nine steps for writing an evidence-based precepting philosophy
Am J Health Syst Pharm. 2023 Dec 27:zxad340. doi: 10.1093/ajhp/zxad340. Online ahead of print.ABSTRACTIn an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.PMID:38150574 | DOI:10.1093/ajhp/zxad340 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 27, 2023 Category: Drugs & Pharmacology Authors: Melissa S Medina Source Type: research

An exploratory mixed-methods evaluation of continuing education opportunities related to the care of sexual and gender minority patients from ACPE-accredited providers
CONCLUSION: Advancement has occurred in the number of available continuing pharmacy education programs focused on the care of SGM patients. Further information regarding specific content and effectiveness of continuing education is necessary to determine strategies to better prepare pharmacy professionals to care for this growing patient population.PMID:38150575 | DOI:10.1093/ajhp/zxad331 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 27, 2023 Category: Drugs & Pharmacology Authors: Joseph A Nardolillo Alex DiLucia Taya Kerwin Samantha R Ramirez Maria C Vazquez Logan T Murry Christopher G Medlin Source Type: research

From ally to accomplice: A call to action to advance LGBTQIA+ health equity
Am J Health Syst Pharm. 2023 Dec 26:zxad336. doi: 10.1093/ajhp/zxad336. Online ahead of print.ABSTRACTIn an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.PMID:38146677 | DOI:10.1093/ajhp/zxad336 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 26, 2023 Category: Drugs & Pharmacology Authors: Alex R Mills Kevin N Astle Kyle Mel ín Source Type: research

Recent and anticipated novel drug approvals for 2023 and 2024
CONCLUSION: Cellular and gene therapies continue to strengthen the pipeline as potential new treatment options for genetic disorders, rare diseases, and cancer. Additional diseases treated by new agents include pulmonary arterial hypertension, chronic obstructive pulmonary disease, diabetes, and obesity.PMID:38146706 | DOI:10.1093/ajhp/zxad337 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 26, 2023 Category: Drugs & Pharmacology Authors: Matthew H Rim Brittany L Karas Farah Barada Andrew M Levitsky Source Type: research

Updates in the treatment of asthma in pediatrics: A review for pharmacists
CONCLUSION: New treatment strategies and agents have emerged in the treatment of pediatric asthma. Pharmacists play a key role in providing education about, dispensing, and recommending the newest evidence-based treatment options for children.PMID:38146826 | DOI:10.1093/ajhp/zxad326 (Source: American Journal of Health-System Pharmacy : AJHP)
Source: American Journal of Health-System Pharmacy : AJHP - December 26, 2023 Category: Drugs & Pharmacology Authors: Tara Smith Kimberly Mills M Petrea Cober Norman E Fenn Carolyn Hill Morgan King Jennifer L Pauley Lea Eiland Caroline Sierra Nicole E Omecene Source Type: research